Dr. Craig Koniver
👤 PersonAppearances Over Time
Podcast Appearances
But if they're not under the guidance of a doctor to help clean up the mess, and we clean up the mess, and not that there's always mess, but this is what we enjoy doing. As a physician, we've seen the darkest of dark. We're able to help people when things don't go perfectly planned, right?
But if they're not under the guidance of a doctor to help clean up the mess, and we clean up the mess, and not that there's always mess, but this is what we enjoy doing. As a physician, we've seen the darkest of dark. We're able to help people when things don't go perfectly planned, right?
And I think that's a big deal, you know, particularly when there's lots of these tools and they're exciting tools and they're great tools.
And I think that's a big deal, you know, particularly when there's lots of these tools and they're exciting tools and they're great tools.
And I think that's a big deal, you know, particularly when there's lots of these tools and they're exciting tools and they're great tools.
And fortunately for me, I've been in this space longer than most that I've just, you know, built up a large repertoire of experience of observing people and working with people and seeing we got to tweak this, we got to nuance this, or sometimes we don't ever want to use this again. You know, this is not for most people. Yeah.
And fortunately for me, I've been in this space longer than most that I've just, you know, built up a large repertoire of experience of observing people and working with people and seeing we got to tweak this, we got to nuance this, or sometimes we don't ever want to use this again. You know, this is not for most people. Yeah.
And fortunately for me, I've been in this space longer than most that I've just, you know, built up a large repertoire of experience of observing people and working with people and seeing we got to tweak this, we got to nuance this, or sometimes we don't ever want to use this again. You know, this is not for most people. Yeah.
Yeah.
Yeah.
Yeah.
So there's a new compound, newer, peptide called, shortened for PDA, pentadeca-arginate. It's basically the same molecular structure as BPC, except they've swapped out an acetate for arginate. One amino acid substitution. Correct. One amino acid substitution. And so we're using that and having really good results.
So there's a new compound, newer, peptide called, shortened for PDA, pentadeca-arginate. It's basically the same molecular structure as BPC, except they've swapped out an acetate for arginate. One amino acid substitution. Correct. One amino acid substitution. And so we're using that and having really good results.
So there's a new compound, newer, peptide called, shortened for PDA, pentadeca-arginate. It's basically the same molecular structure as BPC, except they've swapped out an acetate for arginate. One amino acid substitution. Correct. One amino acid substitution. And so we're using that and having really good results.
Certainly, it's early in the game of using PDA, but it seems very close to BPC in the clinical responses we're getting from our patients who are reporting back decrease in inflammation, all these wonderful things that we used to see with BPC. And I think... I surmise that this is how it's going to be with all of these peptides, right? Because again, peptides are just chains of amino acids.
Certainly, it's early in the game of using PDA, but it seems very close to BPC in the clinical responses we're getting from our patients who are reporting back decrease in inflammation, all these wonderful things that we used to see with BPC. And I think... I surmise that this is how it's going to be with all of these peptides, right? Because again, peptides are just chains of amino acids.
Certainly, it's early in the game of using PDA, but it seems very close to BPC in the clinical responses we're getting from our patients who are reporting back decrease in inflammation, all these wonderful things that we used to see with BPC. And I think... I surmise that this is how it's going to be with all of these peptides, right? Because again, peptides are just chains of amino acids.
Certainly a lot of people smarter than me trying to figure out how do we then create other types of amino acid combinations, i.e. peptides that do similar actions to BPC, to thymus and alpha, to ipamirone, to TB500, on and on and on. So I'm hopeful in that regard. And I also, you know, some of my patients work at the very highest level of the U.S. government.
Certainly a lot of people smarter than me trying to figure out how do we then create other types of amino acid combinations, i.e. peptides that do similar actions to BPC, to thymus and alpha, to ipamirone, to TB500, on and on and on. So I'm hopeful in that regard. And I also, you know, some of my patients work at the very highest level of the U.S. government.
Certainly a lot of people smarter than me trying to figure out how do we then create other types of amino acid combinations, i.e. peptides that do similar actions to BPC, to thymus and alpha, to ipamirone, to TB500, on and on and on. So I'm hopeful in that regard. And I also, you know, some of my patients work at the very highest level of the U.S. government.